Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. (LSTA) — Form 8-K: Current report
About this filing
Lisata Therapeutics, Inc. (LSTA) filed an 8-K on Nov 19, 2026 reporting a change to shareholder rights (Item 3.03), a charter, bylaw or fiscal-year change (Item 5.03) and other events (Item 8.01), with exhibits (Item 9.01).
Key facts
- Item 3.03 · Change to shareholder rights
- Item 5.03 · Charter, bylaw or fiscal-year change
- Item 8.01 · Other events
- Item 9.01 · Financial statements and exhibits
More LSTA filings
- S-3/A
Filed Nov 19, 2026
- 8-K/A
Filed Nov 19, 2026
- 10-Q
Filed Nov 13, 2026
- S-3
Filed Nov 12, 2026
- S-8
Filed Nov 12, 2026
- 8-K/A
Filed Nov 12, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.